Français
Contact Us
1-800-639-0643
Home
Products & Treatments
Uracyst®
NeoVisc®
NMP22® BladderChek®
Customer Support
Business Development
Global Contacts
Uracyst® Global Partners
NeoVisc® Global Partners
Corporate
Investor Relations
Contact Us
Navigation
Home
Investor Relations
Corporate Overview
Officers & Directors
Management Team
Stock Quote
SEC Filings
Press Releases
Request Materials
Contact Us
Contact Us
Stellar Pharmaceuticals Inc.
544 Egerton St
London ON, N5W 3Z8
T: 1-800-639-0643
F: 519-434-4382
Press Releases
<
1
2
3
Release Date
Title (Click to read)
Jul 30, 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
Jul 28, 2010
Stellar Pharmaceuticals Issued Uracyst(R) Patents in the United States and China
Jun 23, 2010
Stellar Pharmaceuticals Allowed Uracyst(R) Patent in United States of America
May 14, 2010
Stellar Pharmaceuticals Reports First Quarter 2010 Financial Results
May 6, 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Germany and Austria
May 5, 2010
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Portugal
<
1
2
3
Copyright © 2011 Stellar Pharmaceuticals Inc. All rights reserved.
Contact Us
1-800-639-0643
